Related Experiment Video
Updated: Jul 30, 2026
09:57
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Desensitization to Mycofenolate Mofetil: a novel 12 step protocol.
M Smith1, A Gonzalez-Estrada1, J Fernandez1
1Cleveland Clinic, Cleveland, OH, USA.
European Annals of Allergy and Clinical Immunology
|July 19, 2016
Summary
Mycophenolate mofetil (MMF) desensitization was successful in a double heart-kidney transplant patient. This case demonstrates a viable protocol for MMF desensitization in complex transplant scenarios.
Area of Science:
- Transplantation immunology
- Pharmacology
- Clinical medicine
Background:
- Mycophenolate mofetil (MMF) is a widely used immunosuppressant in solid organ transplantation.
- Its efficacy and safety profile make it a standard treatment, but desensitization protocols are not well-established.
- Previous MMF desensitization reports have not adhered to current practice parameters.
Observation:
- A patient with a double heart-kidney transplant required MMF therapy.
- The patient underwent a desensitization protocol for MMF.
- This protocol was designed to align with current drug practice parameters.
Findings:
- The MMF desensitization protocol was successful in this double heart-kidney transplant recipient.
- This represents a novel application of MMF desensitization.
- The patient tolerated the MMF therapy post-desensitization.
Implications:
- Successful MMF desensitization offers a potential strategy for patients with hypersensitivity or intolerance.
- This case may inform the development of standardized MMF desensitization protocols.
- Further research is warranted to validate this approach in broader transplant populations.
Related Concept Videos
01:40Cell-mediated Immune Responses
85.9K
Overview
85.9K
01:20Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
57
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
57
01:30Drug Toxicity: Allergic Reactions
104
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
104
01:01Hypersensitivity Reactions: Cytolytic Reactions
89
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
89
01:16Drug toxicity: Idiosyncratic Reactions
127
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
127